Table 3.
Pro- and anti-inflammatory cytokines (pg/ml) from day 7 through 6-months postpartum in women who did or did not score symptomatic of PPD (*P<0.05)
| Day 7 | Day 14 | Month 1 | Month 2 | Month 3 | Month 6 | |
|---|---|---|---|---|---|---|
| IL-6 | ||||||
| EPDS < 10 | 3.13 ± .33 | 1.93 ± .23 | 2.03 ± .25 | 1.91 ± .34 | 2.21 ± .60 | 1.82 ± .22 |
| EPDS ≥ 10 | 2.45 ± .26 | 1.51 ± .20 | 1.47 ± .19 | 1.44 ± .21 | 1.12 ± .17 | 1.35 ± .18 |
|
| ||||||
| IFNγ | ||||||
| EPDS < 10 | 3.38 ± .60 | 2.49 ± .33 | 3.21 ± .46 | 2.08 ± .20 | 3.01 ± 70 | 2.61 ± .44 |
| EPDS ≥ 10 | 2.00 ± .36 | 1.78 ± .24 | 1.83 ± .29 | 2.30 ± .64 | 1.86 ± .36 | 1.87 ± .31 |
|
| ||||||
| TNF-α | ||||||
| EPDS < 10 | 6.65 ± .44* | 6.57 ± .40* | 7.22 ± .44* | 6.65 ± .41* | 7.31 ± .49* | 7.50 ± .62* |
| EPDS ≥ 10 | 4.62 ± .50 | 4.68 ± .45 | 5.10 ± .53 | 4.81 ± .53 | 4.54 ± .47 | 4.64 ± .53 |
|
| ||||||
| IL-1β | ||||||
| EPDS < 10 | 1.15 ± .48 | 0.83 ± .16 | 1.38 ± .58 | 0.99 ± .25 | 0.79 ± .16 | 0.89 ± .23 |
| EPDS ≥ 10 | 0.68 ± .29 | 0.44 ± .07 | 1.31 ± .59 | 0.39 ± .08 | 0.47 ± .13 | 0.46 ± .16 |
|
| ||||||
| IL-10 | ||||||
| EPDS < 10 | 11.2 ± .3.7 | 11.8 ± 5.1 | 12.2 ± 3.9 | 13.6 ± 5.8 | 12.6 ± 4.5 | 13.9 ± 4.9 |
| EPDS ≥ 10 | 3.8 ± .0.8 | 3.6 ± 0.7 | 3.4 ± 0.6 | 3.8 ± 1.2 | 3.0 ± 0.5 | 3.3 ± 0.7 |
|
| ||||||
| IL-8 | ||||||
| EPDS < 10 | 6.05 ± .26 | 6.69 ± .93 | 6.34 ± .97 | 6.24 ± 1.33 | 5.91 ± .94 | 5.96 ± 1.26 |
| EPDS ≥ 10 | 6.09 ± .35 | 6.07 ± .42 | 4.61 ± .28 | 4.75 ± 0.26 | 4.61 ± .32 | 4.62 ± 0.44 |